PIV and PILE scores predict the clinical outcome in patients with metastatic breast cancer treated with CDK4/6 inhibitors
DOI:
10.1007/s10147-025-02770-w
Publication Date:
2025-04-21T12:06:07Z
AUTHORS (4)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (56)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....